News
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...
PrestoDoctor operates a proprietary telemedicine platform developed in-house by Kyle Powers, Co-Founder and CEO. The software includes features for secure video consultations, encrypted patient ...
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2 nd generation antisense oligonucleotide (ASO), in healthy volunteers demonstrated favorable pharmacokinetic (PK) ...
ZUG, Switzerland, August 5, 2025 – MoonLake Immunotherapeutics (NASDAQ:MLTX) (“MoonLake” or the “Company”), a clinical-stage biotechnology company focused on creating next-level therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback